In particular, PP2A silencing in PCa cells has been shown to increase the expression of XIAP protein (via the PP2A/p-eIF4B/XIAP axis), which exerts its antiapoptotic effect by enhancing resistance to DCT [45]. The gene discussed is XIAP; the disease is posterior cortical atrophy.